|
1
|
Tanaka F, Yoneda K and Hasegawa S:
Circulating tumor cells (CTCs) in lung cancer: Current status and
future perspectives. Lung Cancer (Auckl). 1:77–84. 2010.PubMed/NCBI
|
|
2
|
Alix-Panabières C, Riethdorf S and Pantel
K: Circulating tumor cells and bone marrow micrometastasis. Clin
Cancer Res. 14:5013–5021. 2008. View Article : Google Scholar
|
|
3
|
Siravegna G, Marsoni S, Siena S and
Bardelli A: Integrating liquid biopsies into the management of
cancer. Nat Rev Clin Oncol. 14:531–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cabel L, Proudhon C, Gortais H, Loirat D,
Coussy F, Pierga JY and Bidard FC: Circulating tumor cells:
Clinical validity and utility. Int J Clin Oncol. 22:421–430. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW, et al: Circulating tumor cells, disease progression,
and survival in metastatic breast cancer. N Engl J Med.
351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Bono JS, Scher HI, Montgomery RB,
Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ
and Raghavan D: Circulating tumor cells predict survival benefit
from treatment in metastatic castration-resistant prostate cancer.
Clin Cancer Res. 14:6302–6309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krebs MG, Sloane R, Priest L, Lancashire
L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G,
et al: Evaluation and prognostic significance of circulating tumor
cells in patients with non-small-cell lung cancer. J Clin Oncol.
29:1556–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miller MC, Doyle GV and Terstappen LW:
Significance of Circulating Tumor Cells Detected by the CellSearch
System in Patients with Metastatic Breast Colorectal and Prostate
Cancer. J Oncol. 2010:6174212010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka F, Yoneda K, Kondo N, Hashimoto M,
Takuwa T, Matsumoto S, Okumura Y, Rahman S, Tsubota N, Tsujimura T,
et al: Circulating tumor cell as a diagnostic marker in primary
lung cancer. Clin Cancer Res. 15:6980–6986. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoneda K, Tanaka F, Kondo N, Hashimoto M,
Takuwa T, Matsumoto S, Okumura Y, Tsubota N, Sato A, Tsujimura T,
et al: Circulating tumor cells (CTCs) in malignant pleural
mesothelioma (MPM). Ann Surg Oncol. 21 (Suppl 4):S472–S480. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohnaga T, Shimada Y, Moriyama M, Kishi H,
Obata T, Takata K, Okumura T, Nagata T, Muraguchi A and Tsukada K:
Polymeric microfluidic devices exhibiting sufficient capture of
cancer cell line for isolation of circulating tumor cells. Biomed
Microdevices. 15:611–616. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chikaishi Y, Yoneda K, Ohnaga T and Tanaka
F: EpCAM-independent capture of circulating tumor cells with a
‘universal CTC-chip’. Oncol Rep. 37:77–82. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoneda K, Kuwata T, Chikaishi Y, Mori M,
Kanayama M, Takenaka M, Oka S, Hirai A, Imanishi N, Kuroda K, et
al: Detection of circulating tumor cells with a novel microfluidic
system in malignant pleural mesothelioma. Cancer Sci. 110:726–733.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuwata T, Yoneda K, Mori M, Kanayama M,
Kuroda K, Kaneko MK, Kato Y and Tanaka F: Detection of circulating
tumor cells (CTCs) in malignant pleural mesothelioma (MPM) with the
‘Universal’ CTC-Chip and an anti-podoplanin antibody NZ-1.2. Cells.
9:8882020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Husain AN, Colby TV, Ordóñez NG, Allen TC,
Attanoos RL, Beasley MB, Butnor KJ, Chirieac LR, Churg AM, Dacic S,
et al: Guidelines for Pathologic Diagnosis of Malignant
Mesothelioma 2017 Update of the Consensus Statement From the
International Mesothelioma Interest Group. Arch Pathol Lab Med.
142:89–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ordóñez NG: D2-40 and podoplanin are
highly specific and sensitive immunohistochemical markers of
epithelioid malignant mesothelioma. Hum Pathol. 36:372–380. 2005.
View Article : Google Scholar
|
|
19
|
Hinterberger M, Reineke T, Storz M, Weder
W, Vogt P and Moch H: D2-40 and calretinin - a tissue microarray
analysis of 341 malignant mesotheliomas with emphasis on
sarcomatoid differentiation. Mod Pathol. 20:248–255. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Padgett DM, Cathro HP, Wick MR and Mills
SE: Podoplanin is a better immunohistochemical marker for
sarcomatoid mesothelioma than calretinin. Am J Surg Pathol.
32:123–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salomon DS, Brandt R, Ciardiello F and
Normanno N: Epidermal growth factor-related peptides and their
receptors in human malignancies. Crit Rev Oncol Hematol.
19:183–232. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Destro A, Ceresoli GL, Falleni M, Zucali
PA, Morenghi E, Bianchi P, Pellegrini C, Cordani N, Vaira V,
Alloisio M, et al: EGFR overexpression in malignant pleural
mesothelioma. An immunohistochemical and molecular study with
clinico-pathological correlations. Lung Cancer. 51:207–215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dazzi H, Hasleton PS, Thatcher N, Wilkes
S, Swindell R and Chatterjee AK: Malignant pleural mesothelioma and
epidermal growth factor receptor (EGF-R). Relationship of EGF-R
with histology and survival using fixed paraffin embedded tissue
and the F4, monoclonal antibody. Br J Cancer. 61:924–926. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Govindan R, Ritter J and Suppiah R: EGFR
and HER-2 overexpression in malignant mesothelioma. Proc Am Soc
Clin Oncol. 20:31062001.
|
|
25
|
Govindan R, Kratzke RA, Herndon JE II,
Niehans GA, Vollmer R, Watson D, Green MR and Kindler HL: Cancer
and Leukemia Group B (CALGB 30101): Gefitinb in patients with
malignant mesothelioma: a phase II study by the Cancer and Leukemia
Group B. Clin Cancer Res. 11:2300–2304. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohnaga T, Takei Y, Nagata T and Shimada Y:
Highly efficient capture of cancer cells expressing EGFR by
microfluidic methods based on antigen-antibody association. Sci
Rep. 8:120052018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaji C, Tsujimoto Y, Kato Kaneko M, Kato Y
and Sawa Y: Immunohistochemical Examination of Novel Rat Monoclonal
Antibodies against Mouse and Human Podoplanin. Acta Histochem
Cytochem. 45:227–237. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rice D, Rusch V, Pass H, Asamura H, Nakano
T, Edwards J, Giroux DJ, Hasegawa S, Kernstine KH, Waller D, et al
International Association for the Study of Lung Cancer
International Staging Committee and the International Mesothelioma
Interest Group, : Recommendations for uniform definitions of
surgical techniques for malignant pleural mesothelioma: A consensus
report of the international association for the study of lung
cancer international staging committee and the international
mesothelioma interest group. J Thorac Oncol. 6:1304–1312. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Habougit C, Trombert-Paviot B, Karpathiou
G, Casteillo F, Bayle-Bleuez S, Fournel P, Vergnon JM, Tiffet O,
Péoc'h M and Forest F: Histopathologic features predict survival in
diffuse pleural malignant mesothelioma on pleural biopsies.
Virchows Arch. 470:639–646. 2017. View Article : Google Scholar : PubMed/NCBI
|
